Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
117.50    0.00 (0.00%)
Bid:
111.50
Ask:
118.00
Spread: 6.50 (5.83%)
Market Cap: £92.21m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Manufacturing rationalisation

1 Apr 2009 07:00

RNS Number : 8292P
Xaar PLC
01 April 2009
 



FOR IMMEDIATE RELEASE

1 April 2009

Xaar plc

RATIONALISATION OF MANUFACTURING FACILITIES

100 NEW HIGH TECHNOLOGY JOBS TO BE CREATED IN THE UK

Xaar plc ("Xaar" or "the Company"), the inkjet printing technology group headquartered in Cambridge, can confirm that it will now proceed with the rationalisation of its manufacturing facilities.

As part of the proposed rationalisation, approximately 100 new jobs will be created at the Company's 'state of the art' Huntingdon plant over the period of the transfer.

Further to the disclosure of the proposal in the final results announcement on 23 March 2009, the period of consultation with the representatives of the workforce of approximately 130 at the Company's Swedish manufacturing facility in Järfälla, near Stockholm, has now ended. Accordingly, Xaar's Board has decided to proceed with rationalising its production of printheads by transferring manufacturing from the plant in Sweden to its facility in Huntingdon, near Cambridge, and the eventual closure of the Järfälla facility. The process is expected to take about two years to complete in a phased transfer to ensure minimal disruption to the business and continued availability of finished product.

As stated previously, the transfer is expected to achieve:

a substantial reduction in manufacturing costs;
a reduction in management overhead;
better use of production capacity;
improved operational efficiency; and 
the elimination of exchange rate exposure between Sterling and the Swedish Krona.

Ian Dinwoodie, Xaar's Chief Executive, commented:

"We plan to fund the relocation of our Swedish manufacturing activities to Huntingdon with a mix of cash generated from our operations and some external equipment finance. We aim to preserve our cash balances and strong balance sheet."

Ends

 

CONTACTS

Xaar plc:
01223-423663
Ian Dinwoodie, Chief Executive
www.xaar.com
Andrew Taylor, Finance Director
 
 
 
Bankside Consultants:
 
Steve Liebmann or Simon Bloomfield
020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMGGFFFMLGLZM
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.